Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioventus (BVS) Share-based Compensation (2021 - 2026)

Bioventus filings provide 5 years of Share-based Compensation readings, the most recent being $3.4 million for Q4 2025.

  • On a quarterly basis, Share-based Compensation rose 70.63% to $3.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $12.7 million, a 4.53% decrease, with the full-year FY2025 number at $12.7 million, down 4.53% from a year prior.
  • Share-based Compensation hit $3.4 million in Q4 2025 for Bioventus, up from $3.2 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $6.1 million in Q4 2021 to a low of -$2.7 million in Q3 2023.
  • Median Share-based Compensation over the past 5 years was $3.3 million (2022), compared with a mean of $3.3 million.
  • Biggest five-year swings in Share-based Compensation: tumbled 159.19% in 2023 and later surged 311.46% in 2024.
  • Bioventus' Share-based Compensation stood at $6.1 million in 2021, then crashed by 43.82% to $3.4 million in 2022, then crashed by 48.28% to $1.8 million in 2023, then grew by 13.58% to $2.0 million in 2024, then soared by 70.63% to $3.4 million in 2025.
  • The last three reported values for Share-based Compensation were $3.4 million (Q4 2025), $3.2 million (Q3 2025), and $3.6 million (Q2 2025) per Business Quant data.